1 year return (CAGR)
-38.40%
Krebs Biochemicals and Industries Limited Exchange (NSE, INR)
KREBSBIO.NSE
-
+3.58 (+5.94%)
HealthcareDrug Manufacturers - Specialty & Generic
Loading...
3 year return (CAGR)
-15.09%
5 year return (CAGR)
-12.52%
10 year return (CAGR)
-4.20%
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.38B
Price/Sales
5.05
Ent value
4.63B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-7.01%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 64.00 |
| Daily high | 64.00 |
| Daily low | 60.01 |
| Daily Volume | 3K |
| 1y analyst estimate | - |
| Beta | 0.32 |
| EPS (TTM) | -12.74 |
| Dividend per share | 0.00 |
| Ex-div date | 14 Sep 2005 |
| Next earnings date | 18 May 2026 |
Downside potential
Loading...
Downside potential data
| KREBSBIO.NSE | S&P500 | |
| Current price drop from All-time high | -77.92% | -0.89% |
| Highest price drop | -81.99% | -56.47% |
| Date of highest drop | 28 Mar 2023 | 9 Mar 2009 |
| Avg drop from high | -56.31% | -10.67% |
| Avg time to new high | 138 days | 12 days |
| Max time to new high | 3210 days | 1805 days |
News
No items found